NEWS
- PEG‐rhG‐CSF for Neutropenia
- Four Major Trends In The Development of PROTAC
- Overview of The Development of PROTACs
- New Oncology Trends: ADCs, Bispecific Antibodies & CAR-T Cell
- Aptamer-Drug Conjugate (ApDC): Current Research Progress
- FRα Targeting ADCs for Ovarian cancer
- ADC Drugs Targeting Claudin18.2
- Emerging Antibody–siRNA Conjugates (ARC)
- Cleavable & Non-Cleavable PEG Linkers for XDCs
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)